Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

AbCellera (Nasdaq: ABCL) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) ...

Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.

NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

The decision supports stronger international participation, enhanced business opportunities and an impactful launch edition for the region's process industries, directly supporting Vision 2030's ...

Health insurers are increasingly embracing artificial intelligence as part of their business models, bullish on the ...

Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International ...

Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...

United Therapeutics is a Buy: strong core growth, a goal of $1B quarterly revenue by 2027, plus catalysts ralinepag & Tyvaso ...

More than a year after Vietnam began implementing Resolution 57, new innovation models are emerging nationwide while ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has signed five key international agreements during the Saudi-US ...

Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer’s, unlike many names in the ...